• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Immunol . Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset

tetano

Editor, Senior Moderator
J Immunol


. 2021 Dec 13;ji2100727.
doi: 10.4049/jimmunol.2100727. Online ahead of print.
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset


Jaclyn C Law[SUP] 1 [/SUP], Melanie Girard[SUP] 1 [/SUP], Gary Y C Chao[SUP] 1 [/SUP], Lesley A Ward[SUP] 1 [/SUP], Baweleta Isho[SUP] 1 [/SUP], Bhavisha Rathod[SUP] 2 [/SUP], Karen Colwill[SUP] 2 [/SUP], Zhijie Li[SUP] 3 [/SUP], James M Rini[SUP] 3 4 [/SUP], Feng Yun Yue[SUP] 5 [/SUP], Samira Mubareka[SUP] 6 7 [/SUP], Allison J McGeer[SUP] 2 6 [/SUP], Mario A Ostrowski[SUP] 1 5 8 [/SUP], Jennifer L Gommerman[SUP] 1 [/SUP], Anne-Claude Gingras[SUP] 2 3 [/SUP], Tania H Watts[SUP] 9 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces T cell, B cell, and Ab responses that are detected for several months in recovered individuals. Whether this response resembles a typical respiratory viral infection is a matter of debate. In this study, we followed T cell and Ab responses in 24 mainly nonhospitalized human subjects who had recovered from PCR-confirmed SARS-CoV-2 infection at two time points (median of 45 and 145 d after symptom onset). Ab responses were detected in 95% of subjects, with a strong correlation between plasma and salivary anti-spike (anti-S) and anti-receptor binding domain IgG, as well as a correlation between circulating T follicular helper cells and the SARS-CoV-2-specific IgG response. T cell responses to SARS-CoV-2 peptides were determined using intracellular cytokine staining, activation markers, proliferation, and cytokine secretion. All study subjects had a T cell response to at least one SARS-CoV-2 Ag based on at least one T cell assay. CD4[SUP]+[/SUP] responses were largely of the Th1 phenotype, but with a lower ratio of IFN-γ- to IL-2-producing cells and a lower frequency of CD8[SUP]+[/SUP]:CD4[SUP]+[/SUP] T cells than in influenza A virus (IAV)-specific memory responses within the same subjects. Analysis of secreted molecules also revealed a lower ratio of IFN-γ to IL-2 and an altered cytotoxic profile for SARS-CoV-2 S- and nucleocapsid-specific responses compared with IAV-specific responses. These data suggest that the memory T cell phenotype after a single infection with SARS-CoV-2 persists over time, with an altered cytokine and cytotoxicity profile compared with long-term memory to whole IAV within the same subjects.
 
Back
Top Bottom